Johannes Stallhofer

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Ulcerative Colitis

Emergency Department

Top Venues

International journal of colorectal disease

Clinical and translational gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, Philip Christian Grunert, Kathleen Lange, Robert Stalmann, Verena Eckardt, Andreas Stallmach
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. International journal of colorectal disease 38 (1) (2023)
Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, Philip Christian Grunert, Kathleen Lange, Robert Stalmann, Verena Eckardt, Andreas Stallmach
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. International journal of colorectal disease 38 (1) (2023)
Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, Philip Christian Grunert, Kathleen Lange, Robert Stalmann, Verena Eckardt, Andreas Stallmach
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. International journal of colorectal disease 38 (1) (2023)
Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, Philip Christian Grunert, Kathleen Lange, Robert Stalmann, Verena Eckardt, Andreas Stallmach
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. International journal of colorectal disease 38 (1) (2023)
Johannes Stallhofer, Lisa Veith, Julia Diegelmann, Philipp Probst, Stephan Brand, Fabian Schnitzler, Torsten Olszak, Helga Török, Julia Mayerle, Andreas Stallmach, Florian Beigel
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clinical and translational gastroenterology 13 (1) (2022)